Unprocessed bulk material harvested directly from the bioreactor should be tested for contamination prior to downstream processing.
Katherine Marotte
Advertisement
Katherine Marotte is principal scientist, viral safety testing services department, at Eurofins Lancaster Laboratories. She has 14 years of virology experience and specializes in assay development and GMP viral testing.
Articles by Katherine Marotte
Advertisement
Latest Updated Articles
Unprocessed Bulk Testing for BiopharmaceuticalsDecember 1st 2018
Advertisement
Advertisement
Trending on BioPharm International
1
BioPharm Brief: Gene Therapy Progress, FDA Approval, and $103M Funding
2
Opus Genetics’ OPGx-LCA5 Gene Therapy Shows Sustained Vision Gains Ahead of Phase 3
3
FDA Approves Roche’s Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
4
Estuary Biotherapeutics Launches With $103 Million for ADPKD Gene Therapy
5